Introduction
Notch signaling activates a series of highly conserved pathways that regulate cell fate determination. 1 The extracellular domain of Notch is decorated with multiple O-fucose glycans on conserved epidermal growth factor--like (EGF) repeats. 2 The addition of O-fucose to Notch EGF repeats is catalyzed by protein O-fucosyltransferase 1 (Pofut1), [3] [4] [5] and O-fucose on EGF repeats may be elongated by the Fringe family of glycosyltransferases. 6, 7 These fucose-dependent modifications are critical in modulating Notch signaling by altering the sensitivity of Notch receptors to activation by canonical Notch ligands. [8] [9] [10] Fringe-mediated extension of O-fucose has been shown to differentially influence Notch signaling in Drosophila development, in murine embryogenesis, in murine T lymphopoiesis and marginal zone B (MZB) cell development. 8, 9, [11] [12] [13] [14] [15] The O-fucosylation of Notch is essential for Notch signaling and Notch-ligand interactions. [16] [17] [18] [19] To elucidate roles of O-fucose-modified Notch activity in hematopoiesis, we have previously studied FX -/mice that are conditionally defective in de novo GDP-fucose synthesis and glycan fucosylation, but have an intact salvage pathway that can use exogenous fucose to restore wild type fucosylation. 20 Adult FX -/mice exhibit a deficiency in O-linked Notch fucosylation and myeloid hyperplasia due to loss of Notch-induced suppression of myeloid specification and differentiation. 21 Furthermore, FX -/mice display phenotypes that include, but are not limited to, growth retardation, infertility, reduced hematopoietic stem cell count and function, 20-23 and impaired thymocyte development (Y.Man, B.Petryniak, J.Myers, L.Zhou, and J.Lowe, manuscript in preparation). All the abnormal phenotypes observed revert to wild type when the diet of FX -/mice is supplemented with fucose. Abnormal fucose-dependent hematopoietic phenotypes, including neutrophilia and defective T cell development, are mainly associated with altered cell-autonomous Notch activity, 21, 22, 24 Ge et al have shown that removal of an individual O-fucose glycan from the ligand-binding domain of Notch1 cell-autonomously impairs T cell development. 25 However, mice with deletion of Notch1 EGF repeats 8-12 exhibit an embryonic lethal phenotype indistinguishable from Notch1-null mutants. 26, 27 Further, For personal use only. on October 31, 2017. by guest www.bloodjournal.org From homozygous germ line deficiency in Pofut1 yields embryonic lethality with defects in cardiovascular and neurological development. 18, 19 The phenotype of Pofut1-null mutants is analogous to, but more severe than, that observed in single Notch receptor knockout mutants, suggesting a more global defect in Notch signaling caused by Pofut1 deficiency, as expected since all four Notch receptors may carry O-fucose glycans. The combined observations suggest that multiple O-fucose glycans are critical to normal Notch1 function.
In this study, to further refine our understanding of roles for O-fucosylation on Notch function in postnatal hematopoiesis, we characterized hematopoiesis in mice with inducible Pofut1 deficiency. In these mice, inactivation of the Pofut1 locus abolishes the transfer of Olinked fucose to a small subset of glycoproteins with appropriate EGF repeats, including Notchfamily receptors and ligands, while other forms of fucose-containing glycans remain normal. 28 We show here that induced deletion Pofut1 in adult mice gives rise to aberrant MZB formation, myeloid hyperplasia, and thymic hypoplasia. The latter two phenotypes can be largely corrected by expression of the intracellular domain of Notch1. Reciprocal transplantation experiments involving Pofut1-deleted donors and Pofut1 wild-type (WT) recipients, and vice versa, revealed that both T and MZB cell developmental defects as well as myeloid hyperplasia were mainly marrow cell-autonomous. However, an enhanced phenotype was observed in a Pofut1-null environment. Furthermore, a fucose-dependent dosage effect of Pofut1 in FX -/mice indicates an essential role of Pofut1 in O-fucose modified Notch signaling in suppression of overt myelopoiesis.
Materials and Methods

Mice
Animal protocols were approved by the Case Western Reserve University Institutional Animal Care and Use Committee. Floxed Pofut1 (Pofut1 F/F ) mice and Pofut1 heterozygous mice (Pofut1 +/-) were previously described. 18 Pofut1 +/-/FX -/mice were generated by breeding the For personal use only. on October 31, 2017. by guest www.bloodjournal.org From progeny of Pofut1 +/and previously described FX -/mice. 20 Mx-Cre transgenic mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and used to generate Mx-Cre/Pofut1 F/F . To induce Pofut1 inactivation, 3 doses of 250µg pIpC (Sigma-Aldrich, St. Louis, MO) were administered intraperitoneally to 4-week-old animals every other day. Deletion efficiency was confirmed by PCR genotyping of marrow genomic DNA one month later. In some of the experiments, mice received an additional 2 doses of pIpC weekly; however, the deletion efficiency was similar whether using 3 or 5 doses of pIpC. Genotyping of thymic or marrow stroma were performed by immunodepletion of cells expressing CD45, TER119 and CD31 using biotinylated anti-mouse antibodies and anti-rat IgG magnetic beads (Miltenyi Biotech, Auburn, CA). Genotyping primer sequences are described in Figure S1 .
Flow cytometric analysis
Isolation of LSK cells (Lin -Sca1 + c-kit + ) was performed as described. 21 Notch expression on LSK cells was detected by phycoerythrin (PE)-anti-Notch1-4 isoforms (Biolegend, San Diego, CA). For staining of intracellular TCRβ and TCRγδ on DN4 thymocytes, after cells were first stained with PE-Cy7-anti-CD4/CD8, allophycocyanin (APC)-Cy7-anti-CD 44 and PE-anti-CD25, cells were fixed with 2% paraformaldehyde and then stained with fluorescein isothiocyante (FITC)-anti-TCRβ and APC-anti-TCRγδ (eBioscience, San Diego, CA). Flow cytometry analysis was performed on a FACSAria and data analyzed using FACS Diva software.
LSK differentiation in OP9 co-culture assays and quantitative RT-PCR analysis LSK differentiation on OP9 cells expressing Notch ligands was performed as described. 21 Briefly, LSK cells were cultured with OP9 cells for 20 days on OP9-control or OP9-Dll4 in the presence of IL-7 (5 ng/ml) and Flt3L (5 ng/ml). The Notch signaling inhibitor GSI (L-685,458, Sigma-Aldrich, St. Louis, MO) was supplemented at 10μm in cultures where indicated. Cell
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From differentiation at the end of the culture was determined by anti-CD4/8, APC-anti-Gr-1, and anti-B220 (eBioscience, San Diego, CA). Quantitative RT-PCR analysis was performed on cells cultured for 4 days as described previously. 21 
Bone marrow transplantation
Donor-derived bone marrow cells (2X10 6 ) isolated from either WT (Ly5.2) or pIpCtreated Mx-Cre/Pofut1 F/F (Ly5.2) mice were delivered via tail vein to lethally irradiated (9.5 Gy) WT (Ly5.1) or Mx-Cre/Pofut1 F/F recipients. One month after injection, all recipient mice received 3 doses of 250 µg of pIpC. Three months after transplantation, cells from hematopoietic organs were collected for analysis.
Bone marrow transplantation with retrovirally-transduced cells
A retrovirus vector containing constitutively active Notch1 intracellular domain (ICN1) was prepared as described. 22 Briefly, Phoenix E cells were transiently transfected with either pMig-ICN1-EGFP or empty vector (pMig-EGFP) bicistronic constructs using the Profection mammalian transfection system (Promega, Madison, WI). Viral supernatants were collected on three consecutive days 24 hours after the transfection. Bone marrow cells collected after 5-FU treatment were suspended in viral supernatant containing growth medium and 4 µg/ml of Polybrene (Millipore, Billerica, MA). Forty-eight hours following the infection, 2-5 × 10 5 infected cells along with 2 × 10 5 WT cells were transferred into lethally irradiated recipients.
Recipients were sacrificed at 3-4 weeks after transplantation and single-cell suspensions of hematopoietic organs were prepared and analyzed.
Soluble Notch ligand binding assay
Soluble Dll4 ligand fused to the Fc region of human IgG1 (Dll4-Fc) and Dll1-Fc were prepared from HEK 293T cells as described. 21 Enzyme-linked immunoadsorbent assay was 
Statistical Analysis
Data are reported in the format of mean ± standard deviation unless otherwise stated.
Statistical significance was assessed by Student t test.
Results
Myeloid hyperplasia and impaired lymphopoiesis in mice lacking Pofut1
Our recent studies revealed a myeloproliferative phenotype, HSC dysfunction, and abnormal Notch signaling in mice lacking GDP-4-keto-6-deoxymannose 3,5-epimerase-4reductase (the FX enzyme), an enzyme required for the de novo synthesis of the fucosyltransferase substrate GDP-fucose. 21, 22 Deletion of FX not only eliminates O-fucose on Notch but also may affect other fucyosyltransferase activities, eg Fut 4 and Fut7 decorated selectin ligand interaction with selectin that can influence myeloid homeostasis, and Pofut2 that mediates fucosylation of thrombospondin type 1 repeats. 24, 29 To determine specific roles for Notch O-fucosylation in hematopoiesis, we investigated whether inactivation of the Pofut1 gene that encodes the enzyme responsible for the addition of O-linked fucose to multiple EGF repeats on Notch, would result in a similar phenotype. We therefore generated a Mx-Cre/Pofut1 F/F mouse ( Fig S1A) to induce the deletion of the Pofut1 locus post-natally via pIpC-dependent induction of Cre expression. 30 In young adult mice assessed one month after pIpC injection, deletion of the Pofut1 locus was nearly complete in bone marrow cells and marrow stroma ( Fig S1B-C) . At 3-5 months after pIpC injection, Mx-Cre/Pofut1 F/F mice developed neutrophilia in the peripheral For personal use only. on October 31, 2017. by guest www.bloodjournal.org From blood (PB) with neutrophil numbers of 6.0±2.0X10 3 /μl compared to 0.7±0.2X10 3 /μl in control mice ( Fig 1A) . This was accompanied by a decrease in both the percentage and absolute number of T lymphocytes in PB. While the percentage of B lymphocytes in PB was also decreased ( Fig   1B) , the absolute number was not changed due to splenomegaly in Mx-Cre/Pofut1 F/F mice ( Fig   1E) . In the marrow there was a decrease in T and B lymphocytes and an expansion of mature granulocytes and myeloid progenitors ( Fig 1C & D) . In addition to splenomegaly, Mx-Cre/Pofut1 F/F mice displayed infiltration of the spleen by mature granulo-monocytic cells and myeloid progenitors ( Fig 1E & F) . The platelet numbers in the PB of Mx-Cre/Pofut1 F/F mice were not changed when compared to control mice (data not shown).
Further characterization of the lymphoid compartment in pIpC-treated Mx-Cre/Pofut1 F/F
mice revealed that the thymus was drastically decreased in size compared to controls (total thymocytes in each lobe: 0.5±0.3X10 6 ; control: 45±4.8X10 6 ) (Fig 2A &B) . Flow cytometric analysis revealed that the percentage and the absolute numbers of mature thymic T cell subsets (CD4 + SP, CD8 + SP, and CD4 + CD8 + DP) were significantly reduced in Mx-Cre/Pofut1 F/F mice, while the percentage of immature DN (CD4 -CD8 -) thymocytes were increased ( Fig 2C) . In the DN4 subset, the percentage of cell surface and intracellular α β T cells was decreased while γ δ T cells were not changed ( Fig 2C) . The block to T cell development in the thymus of Mxcre/Pofut1 F/F mice occurred at the DN1 stage (CD44 + CD25 -) (78±14% of DN; control: 10±5.0% of DN). The numbers of B220 + lymphocytes in the thymus were variably increased ( Fig 2D) . In the spleen, the percentage of T lymphocytes was decreased while the percentage of B cells was relatively unchanged ( Fig 1F) . Further analysis of the B lymphoid compartment in Mx-Cre/Pofut1 F/F mice revealed no obvious blockage of B cell progenitor development (data not shown). However, there was a 10-fold decrease in the number of B220 + IgM hi IgD lo B cells comprising type1 transitional (T1) and MZB cells (Fig 2E) , and a 34-fold decrease in the number of MZB cells (B220 + CD21 high CD23 lo/-), 31 when compared to control mice ( Fig 2F) .
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From In summary, the markedly reduced T cell development in the thymus and MZB development in spleen in Mx-Cre/Pofut1 F/F mice largely recapitulated the phenotype of thymus in Notch1 conditional-knockout mice 32 and of spleen in Notch2 conditional-knockout mice, 31 respectively. The generation of both aberrant lymphoid development and myeloproliferation is similar to the results reported for FX -/mice, 21 indicating that Pofut1 modulates pan-Notch signaling in both lymphoid and myeloid lineages.
Because Pofut1 modifies not only Notch receptors but also other proteins such as Cripto, agrin, and clotting factors, 7, 28, [33] [34] [35] , we investigated hematopoietic tissue-specific inactivation of Pofut1 via crossing the Pofut1 F/F mice to Vav-Cre transgenic mice. 36 Analyses of Vav-Cre/Pofut1 F/F mice confirmed that Pofut1-deletion in hematopoietic tissues resulted in myeloid hyperplasia and T cell as well as MZB cell development defects ( Fig 2S) . When compared to control mice (Pofut1 F/F ), the Vav-Cre/Pofut1 F/F mice showed a 2.2-fold increase of neutrophils in the PB, a marked expansion of mature granulocytes and a 50% increase in myeloid progenitors in the marrow, and splenic infiltration of Gr-1 + cells. The thymocyte numbers were decreased by 76% with the majority being at the DN1 stage, while MZB cells were decreased ~70-fold.
Lymphoid and myeloid defects in Pofut1-deleted mice arose largely from cell-autonomous mechanism(s) but also environmental cues Genetic traits are often intricately regulated by both cell-autonomous events and environmental factors. To discriminate between these two processes in the context of the lymphoid and myeloid phenotypes observed in Mx-Cre/Pofut1 F/F mice, we performed bone marrow transplantation experiments where WT (Pofut1 F/F ) marrow cells, or pIpC-treated Mx-Cre/Pofut1 F/F cells were delivered to lethally-irradiated WT recipients, or pIpC-treated Mx-Cre/Pofut1 F/F recipients, respectively. All recipients received 3 doses of pIpC one month later to ensure maximal deletion of Pofut1. Three months post transplantation, donor contributions to For personal use only. on October 31, 2017. by guest www.bloodjournal.org From hematopoietic reconstitution was assessed by immunophenotyping of cells in the PB, thymus, spleen, and marrow.
The Pofut1locus was fully inactivated in blood and marrow cells isolated from mice receiving Pofut1-null cells ( Fig S3A) . Neutrophil numbers were mildly elevated in Pofut1-deleted recipients receiving WT cells, but were elevated 5.2-fold in WT recipients receiving Pofut1deleted cells, and further increased in Pofut1-deleted recipients receiving Pofut1-null cells (6.6fold) ( Fig 3A) . This myeloid hyperplasia phenotype was also observed in the marrow of recipients receiving Pofut1-null cells, with an ~2-4 fold increase in the number of cells in the GMP compartment compared to recipients receiving WT cells ( Fig 3B) . Visually, spleens were moderately to markedly enlarged in mice transplanted with Pofut1-null cells regardless of the recipient genotype. Characterization of the cellular composition of spleens showed an enhanced proportion of the Gr-1 + myeloid compartment ( Fig 3C) and a corresponding reduction of T lymphocytes (data not shown). Analysis of B220 + cells revealed that the MZB cells were decreased by ~ 70% in WT recipients receiving Pofut1-null cells, and further decreased in In the thymus, the total thymocyte number was mildly decreased in Pofut1-deleted recipients receiving WT marrows. By contrast, thymocyte number was reduced by 70% overall in WT recipients receiving Pofut1-null cells, or by > 93% in Pofut1-deleted recipients receiving Pofut1-null cells ( Figure 3F ). The increased DN T cells in mice receiving Pofut1-null cells were mainly at the DN1 stage, recapitulating the thymocyte phenotypes observed in Mx-Cre/Pofut1 F/F mice ( Figure 3G-3H ). PCR genotyping of double positive thymocytes present in some WT recipients receiving Pofut1-null cells disclosed them to be of non-deleted progenitor origin. By contrast, genotyping of sorted DN T cells indicated that these cells were fully null for the Pofut1 locus ( Fig S3C) . In fact, two WT mice receiving Pofut1-null cells had markedly decreased thymocyte numbers (0.4 X10 6 and 1.2 X10 6 ), with cells composed of mainly stromal cells and DN cells. In these mice, complete deletion of Pofut1 was confirmed by PCR on total thymocytes. PU.1 and C/EBPα, were increased in Mx-Cre/Pofut1 F/F -derived LSKs, relative to WT LSKs (2.1and 1.8-fold increase, respectively) ( Fig S4) .
Therefore aberrant T and MZB cell development as well as myeloid hyperplasia in
To investigate mechanisms underlying the suppressed Notch activity of LSKs in the absence of Pofut1, we first examined the cell surface expression of Notch receptors, since Pofut1 has been implicated in Notch receptor surface expression in Drosophila. 5, 37 Notch1 and Notch2 cell surface expression were decreased by ~31% and 33%, respectively, in LSKs ( Fig 4C) , and were decreased by ~20% in DN thymocytes from Mx-Cre/Pofut1 F/F mice after deletion of Pofut1( Fig S5A) . A mild decrease of total Notch1 and Notch2 in Pofut1-deleted LSKs was also noted ( Fig S5B) . Notch3 expression was not changed in LSKs from Mx-Cre/Pofut1 F/F mice ( Fig   4C) , while Notch4 was barely detected (data not shown). Because O-fucose glycans have been implicated in Notch receptor-ligand interactions, 17, 21, 38 we then examined the binding of Pofut1deleted progenitors with recombinant Notch ligands. The recombinant Dll1 and Dll4 were expressed from HEK293T cells ( Fig S6A) and displayed Notch-specific, Ca ++ -dependent, bindings with WT LSKs (Fig 4D) and hematopoietic progenitors differentiated from embryonic stem cells ( Fig S6B) . When probed with soluble Notch ligands, Pofut1-deleted LSK cells displayed ~90% reduction of binding by Dll4 and Dll1 in the presence of Ca ++ (Fig 4D) . For personal use only. on October 31, 2017. by guest www.bloodjournal.org From bicistronic configuration with GFP, or with a control vector also expressing GFP (pMig). Three to four weeks following transplantation, donor-derived blood cells were characterized. We found that the total white cell counts were 1.2±0.5X10 3 /μl in mice received Pofut1-null cells expressing ICN1, and 2.8±1.1X10 3 /μl in mice received Pofut1-null cells transduced with the pMig, respectively. Analysis of T cells and granulocytes in GFP + cells revealed that, the frequency of CD4 + /CD8 + T cells in WT mice receiving ICN1-expressing cells was increased (43%) and the frequency of Gr-1 + cells was decreased (14%), when compared to those in mice who received pMig transduced donor cells (7% for T cells and 48% for granulocytes) (Fig 5A-B) . The T cell and granulocyte frequencies in GFP -(non-transduced) populations remained unchanged ( Fig 5C-D ). In the marrow, an increase of DP T cell frequency and a decrease of granulo-monocytic cells were also observed in mice receiving Pofut1-null cells expressing ICN1 ( Fig S7) . Similar to our findings of ICN1-transduction of FX -/marrow progenitors, 22 ICN1 expression suppressed the myeloid progenitor expansion in the marrow but not in spleen (data not shown). Altogether, these data indicate that constitutively active Notch1 efficiently reverses the aberrant hematopoietic development in T and myeloid lineages from marrow progenitors lacking Pofut1. Furthermore, these findings support our previous observation that O-fucose-dependent Notch activity plays a functional role in lineage specification between lymphopoiesis and myelopoiesis during development. 22 
Heterozygosity of Pofut1 affects rescue of FX -/mice myeloid hyperplasia by exogenous fucose
To further investigate roles for Pofut1 in Notch signaling, we asked if haploinsufficiency of Pofut1could lead to aberrant myeloid differentiation or T lymphopoiesis. We observed as reported previously, 25 that Pofut1 +/mice on a WT FX background had a normal distribution of mature T cells in the periphery ( Fig 6A) and thymus ( Fig S8) , as well as essentially wild type numbers of neutrophils and B cells ( Fig 6A) , and normal platelet numbers (Pofut1 +/-: (Fig 6B & 6F) . The ratio of GMP/CMP in these mice was increased from 1.44±0.54 to 4.84±1.2 in Pofut1 +/+ /FX -/mice, and from 1.55±0.11 to 5.82±2.2 in Pofut1 +/-/FX -/mice, respectively (Table 1) . Salvage pathway-dependent titration of GDP-fucose synthesis was achieved by providing the mice with water containing a range of concentrations of fucose. Four weeks after fucose replenishment, all mice had significantly decreased neutrophil numbers in their periphery. In mice receiving water containing 5 mM fucose, neutrophil numbers were essentially the same in Pofut1 +/-/FX -/mice and in Pofut1 +/+ /FX -/mice. By contrast, Pofut1 +/-/FX -/mice receiving 1mM or 2.5mM fucosewater maintained higher neutrophil counts in their periphery than Pofut1 +/+ /FX -/mice also receiving 1mM or 2.5mM fucose-water ( Fig 6B) . After 8-weeks of fucose replenishment, mice receiving 5mM fucose completely corrected their neutrophilia regardless of their Pofut1 genotype. By contrast, we observed a delayed correction of neutrophilia in Pofut1 +/-/FX -/mice receiving either 1 mM or 2.5 mM fucose-water, relative to Pofut1 +/+ /FX -/mice also receiving 1 mM or 2.5 mM fucose-water ( Fig 6C-E) . The delayed neutrophil recovery observed in Pofut1 +/-/FX -/mice after 4-weeks of fucose supplementation was accompanied by an attenuated correction For personal use only. on October 31, 2017. by guest www.bloodjournal.org From of GMP expansion in the marrow, such that the ratios of GMP/CMP in Pofut1 +/-/FX -/mice receiving all concentrations of fucose-water were higher than those in Pofut1 +/+ /FX -/mice ( Fig   6F, Table 1 ). These observations demonstrate that graded diminution of the Pofut1 substrate GDP-fucose sensitizes the Notch signaling pathway to Pofut1 haploinsufficiency, thereby reinforcing the role of Pofut1-dependent fucosylation in the control of myelopoiesis.
Discussion
In this study, we demonstrated that conditional deletion of Pofut1 postnatally leads to aberrant T-, myeloid-, and B-lineage development in adult mice. The blocked T lymphoid development at or before the DN1 stage in thymus is identical to mice carrying conditional deficiency of Notch1 or RBP-J. 32, 41 However, it is more severe than observed in mice carrying a point mutation in Notch1 EGF12 that removed the single O-fucose glycan site in the Notch1 ligand binding domain. 25 This provides evidence that O-fucose glycans in other regions of the Notch1 extracellular domain are important for Notch1 activity, consistent with observations in lck-Lfng transgenic mice homozygous for the EGF12 mutation and in cell-based assays with various Notch1 EGF mutations. 15, 42 In the B lymphoid compartment, the absence of Pofut1 led to complete depletion of MZB cell development known to be mediated by Notch2 signaling in spleen. 31 Consistent with our previous findings in FX -/mice, 21 Previous studies indicate that Notch1 signaling cell-autonomously modulates T cell specification and differentiation. 25, 32, 41 Our studies here support the conclusion that O-fucose glycans also modulate T lymphopoiesis in a cell-autonomous fashion, given that Pofut1-deleted marrow progenitor cells were unable to proceed beyond an early T cell developmental in the context of a WT environment. Similarly, Pofut1 regulates Notch2 signaling cell-autonomously in MZB cells. We interpret the residual T cell and MZB differentiation in those recipients to have arisen from donor cells that escaped Pofut1 deletion. Intriguingly, we found an appreciable reduction in thymocytes and MZB cells in Pofut1-deleted recipients who received WT marrows, suggesting that there may be a marrow-independent component in Pofut1-deleted stroma relevant to Notch regulated processes. Possible candidates for hematopoietic cell-independent component are one or more Notch ligands expressed in recipient stroma. It is known that Pofut1-mediated Ofucose glycans modify both Notch receptors and Notch ligands. 46 For personal use only. on October 31, 2017. by guest www.bloodjournal.org From A similar myeloid hyperplasia phenotype as identified in Pofut1-deleted mice was also described in mice deficient in Mind bomb1 (Mib1), 48 an E3 ubiquitin ligase that is essential for Notch ligand endocytosis. These observations support the notion that dysfunctional Notch signaling, due either to a Notch receptor defect, or a Notch ligand defect, or both, leads to expansion of the myeloid compartment. Support for this hypothesis derives from results here, where we observe enhanced myeloid potential with mild neutrophilia, either when the myelopoietic potential of Pofut1-deleted cells is examined in a WT host, or when WT donors are examined in a Pofut1-deleted host. Furthermore, in the setting where both cells and the environment are deficient in Pofut1, we observe a more severe myeloid phenotype than obtained when either the donor or recipient is Pofut1-deficient. Together, these observations indicate that the myeloid hyperplasia phenotype observed in Pofut1-deleted mice, derives from a combination of loss of O-fucose glycans on the EGF repeats of Notch receptors expressed on marrow progenitors and loss of Pofut1-dependent O-fucose glycans expressed by the marrow environment. Clearly, on the progenitor cell side, Notch and its fucosylation are the predominant controlling factors. 21 Given that fucose-deficient progenitors are localized more distantly to the endosteum, 23 micro-environmental location of progenitors within the marrow is likely also to modulate myeloid homeostasis. On the marrow environmental side, the identity, location and Ofucosylated glycoprotein repertoire of the cell type(s) that contribute to maintaining myelopoietic homeostasis are yet to be identified. However, these could include osteoblasts or endothelial cells that may use Notch ligands to support stem cell function in the marrow, 49, 50 , or cells that express as yet unidentified stromal glycoproteins that are modified by EGF O-fucose, and somehow directly or indirectly modulate myelopoiesis. These considerations highlight the significance of post-translational glycosylation in fine tuning Notch function in mammalian hematopoiesis.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From Table 1 . Haploinsufficiency of Pofut1 shows impaired correction of myeloid progenitor hyperplasia in FX -/background. Pofut1 +/-/FX -/or Pofut1 +/+ /FX -/mice were maintained on fucose-supplemented chow (0.5% fucose w/w) until 8 wks old after birth and then maintained on standard chow without fucose supplementation for one month. Mice were then fed water containing various concentrations of fucose as shown in Fig 6. Four weeks later, marrow progenitors were analyzed by FACS. Populations of CMP or GMP are shown as percentages of Lin -Sca-1 -IL7Rc-kit + cells. Data shown are mean ± SD. Shown also are CMPs and GMPs from 8 wk-old-mice maintained on fucosesupplemented water (4 weeks on fucose) or standard chow (4 weeks without fucose). *Student's t-test was performed to compare the GMP/CMP ratios in Pofut1 +/-FX -/mice with those in Pofut1 +/+ FX -/mice. Table 1 . Student t-test was performed to compare the cell numbers from Pofut1 +/-(FX -/-) with those from Pofut1 +/+ (FX -/-) mice, or from Pofut1 +/-/FX -/mice to those from Pofut1 +/+ /FX -/-(A-E). Data shown are mean ± SD. P values that are significantly different are shown as indicated.
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